SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase
摘要:
A novel class of 5-lipoxygenase (5-LO) inhibitors characterized by a central imidazo[1,2-a] pyridine scaffold, a cyclohexyl moiety and an aromatic system, is presented. This scaffold was identified in a virtual screening study and exhibits promising inhibitory potential on the 5-LO. Here, we investigate the structure-activity relationships of this compound class. With N-cyclohexyl-6-methyl-2-(4-morpholinophenyl)imidazo[1,2-a]pyridine-3-amine (14), we identified a potent 5-LO inhibitor (IC50 = 0.16 mu M (intact cells) and 0.1 mu M (cell-free)), which may possess potential as an effective lead compound intervening with inflammatory diseases and certain types of cancer. (C) 2012 Elsevier Ltd. All rights reserved.
SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase
作者:Martina Hieke、Carmen B. Rödl、Joanna M. Wisniewska、Estel. la Buscató、Holger Stark、Manfred Schubert-Zsilavecz、Dieter Steinhilber、Bettina Hofmann、Ewgenij Proschak
DOI:10.1016/j.bmcl.2012.01.038
日期:2012.3
A novel class of 5-lipoxygenase (5-LO) inhibitors characterized by a central imidazo[1,2-a] pyridine scaffold, a cyclohexyl moiety and an aromatic system, is presented. This scaffold was identified in a virtual screening study and exhibits promising inhibitory potential on the 5-LO. Here, we investigate the structure-activity relationships of this compound class. With N-cyclohexyl-6-methyl-2-(4-morpholinophenyl)imidazo[1,2-a]pyridine-3-amine (14), we identified a potent 5-LO inhibitor (IC50 = 0.16 mu M (intact cells) and 0.1 mu M (cell-free)), which may possess potential as an effective lead compound intervening with inflammatory diseases and certain types of cancer. (C) 2012 Elsevier Ltd. All rights reserved.